A detailed history of Hudson Bay Capital Management LP transactions in Catalent, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 1,118,269 shares of CTLT stock, worth $71 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,118,269
Previous 3,231,723 65.4%
Holding current value
$71 Million
Previous $182 Million 62.73%
% of portfolio
0.31%
Previous 0.98%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $119 Million - $129 Million
-2,113,454 Reduced 65.4%
1,118,269 $67.7 Million
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $1.7 Million - $1.81 Million
-31,731 Reduced 0.97%
3,231,723 $182 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $119 Million - $167 Million
2,784,439 Added 581.28%
3,263,454 $184 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $5.67 Million - $8.21 Million
176,318 Added 58.25%
479,015 $21.5 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $5.62 Million - $6.39 Million
-127,244 Reduced 29.6%
302,697 $13.8 Million
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $7.03 Million - $14.8 Million
220,584 Added 105.36%
429,941 $18.6 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $9.51 Million - $15.5 Million
209,357 New
209,357 $13.8 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $18.5 Million - $22.7 Million
-215,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $11.8 Million - $15 Million
162,500 Added 309.52%
215,000 $18.4 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $840,350 - $1.38 Million
17,500 Added 50.0%
52,500 $3.85 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $1.29 Million - $2.2 Million
35,000 New
35,000 $1.82 Million
Q4 2019

Feb 12, 2020

SELL
$47.06 - $56.64 $4.71 Million - $5.66 Million
-100,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$47.45 - $58.05 $4.75 Million - $5.81 Million
100,000 New
100,000 $4.77 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.